The Federal Trade Commission on Friday sued prescription-drug middlemen owned by CVS Health Corp., Cigna Group and UnitedHealth Group Inc., alleging that they artificially pumped up prices of ...

FTC sues three largest drug middlemen for allegedly inflating insulin prices by Nathaniel Weixel - 09/20/24 4:17 PM ET. by Nathaniel Weixel - 09/20/24 4:17 PM ET.

The filing points out the average cost of a brand-name insulin drug in 1999 was $21, but increased to more than $274 by 2017, an increase of 1,200%.

FTC Sues Drug Middlemen Over Manipulating Insulin Market. Lower-cost versions of insulin weren’t covered by group plans; Drug benefit managers accused of illegally inflating prices ...